Stanford postdoc Ashley Styczynski wins Rosenkranz Prize

Stanford postdoc ASHLEY STYCZYNSKI, winner of the Rosenkranz Prize, will investigate the epidemiology behind the alarmingly high rate of stillbirths in Bangladesh while helping prepare for the coming onslaught of the new coronavirus in the densely populated South Asian nation.

Ashley Styczynski (center) evaluating the setup in one military hospital in Dhaka, Bangladesh, in preparation for COVID-19 patients. There is only one ventilator available for every 100,000 people in the South Asian nation. (Courtesy Ashley Styczynski)

Most of the stillbirths that occur around the world are among women who live in low- and middle-income countries. Some 2.5 million women suffer the heartbreaking loss each year.

Yet determining the causes and prevention of stillbirths has largely been ignored as a global health priority – the incidence not even included in the WHO Millennium Development Goals.

Styczynski discovered the alarmingly high level of stillbirths while working in Bangladesh as a 2019-20 Fogarty Fellow, studying antimicrobial resistance in newborns in the hospitals there.

“No one is more deserving of the Rosenkranz Prize than Dr. Ashley Styczynski,” said RICARDO ROZENKRANZ. “Because of her tenacity, originality and focus, Dr. Styczynski exemplifies the ideal Rosenkranz Prize recipient.”

The $100,000 Rosenkranz Prize is awarded to a Stanford researcher who is doing innovative work to improve health in the developing world.

The Rosenkranz Prize was started and endowed by the family of the late Dr. George Rosenkranz, who devoted his career to improving health care access across the world and helped synthesize the active ingredient for the first oral birth control pill.

Read the full article on the Stanford Health Policy website.